Last reviewed: June 28, 2026
Last updated: June 28, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Zepbound (tirzepatide) and Wegovy (semaglutide) are both FDA-approved GLP-1 receptor agonists that help people lose weight by reducing appetite and blood sugar. In head-to-head clinical trials, tirzepatide users lost approximately 3–5% more body weight than semaglutide users over 68 weeks, though both medications deliver substantial results for most patients.
How Zepbound and Wegovy Work Differently in Your Body
Wegovy contains semaglutide, which activates one receptor pathway in your brain and gut called GLP-1. This signal tells your body to eat less and helps stabilize blood sugar between meals. Semaglutide has been studied extensively since its development for diabetes, giving it a long safety track record in clinical practice.
Zepbound contains tirzepatide, a newer dual-action medication that activates both GLP-1 and GIP receptors. By targeting two pathways instead of one, tirzepatide creates a stronger appetite-suppressing effect and may boost your metabolic rate more effectively. This dual mechanism explains why some patients experience faster weight loss with tirzepatide compared to single-receptor medications.
Weight Loss Results: Clinical Trial Data for Zepbound vs Wegovy
In the pivotal SURMOUNT-1 trial, adults taking tirzepatide at the highest dose lost an average of 22.5% of their body weight over 72 weeks. In comparison, the STEP-4 trial showed semaglutide users at the highest dose lost approximately 17.4% of body weight in a similar timeframe. This 5% difference may sound modest, but it represents an additional 10–15 pounds for someone weighing 200 pounds.
Both medications show dose-dependent results, meaning higher doses generally produce more weight loss. However, individual variation is significant—some people lose 30% or more of their body weight, while others experience more modest reductions. Genetic factors, including variants in your GLP-1 receptor and GIPR genes, influence how strongly you respond to each medication type.
Cost Comparison: Brand-Name vs Compounded Options
Zepbound and Wegovy brand-name injections typically cost $900–$1,300 per month without insurance coverage. Many patients must navigate prior authorization delays or insurance denials, adding weeks to treatment start times. PlexusDx provides compounded tirzepatide injection from licensed 503A pharmacies starting at $249/mo, with no insurance requirement and HSA/FSA eligibility.
Compounded medications contain the same active pharmaceutical ingredients as brand-name versions but are manufactured by licensed pharmacies rather than pharmaceutical manufacturers. PlexusDx compounded tirzepatide delivers the dual-receptor mechanism of Zepbound at a fraction of the cost, making advanced weight loss therapy accessible without membership fees or enrollment delays.
Why Your Genetic Profile Predicts Which Medication Fits You Best
Not everyone responds equally to semaglutide or tirzepatide because genetic differences affect how your body processes hunger signals. Variants in the GLP1R gene (like rs6923761) influence how sensitively your GLP-1 receptors respond to medication, while GIPR variants (like rs1800437) determine your potential benefit from dual-receptor activation. Some patients have genetic profiles that predict stronger response to tirzepatide, while others may do equally well on semaglutide.
PlexusDx Precision Peptide Genetic Test maps 14 pathways and 49 peptides to reveal your unique weight loss biology. This peptide-pathway genetic test (not pharmacogenomic) identifies which GLP-1 option aligns with your body's metabolic strengths, helping you avoid medication switching delays and optimize results from the start. After your first month of treatment, the genetic test is available as a $99 add-on.
Side Effects and Tolerability: What to Expect
Both tirzepatide and semaglutide cause similar side effects during the first weeks of treatment, including mild nausea, vomiting, and constipation. These gastrointestinal symptoms typically subside as your body adapts over 2–4 weeks. Tirzepatide users report slightly higher rates of nausea in trials, but serious adverse events remain rare for both medications when dosed appropriately.
Dehydration and electrolyte imbalance can occur if you reduce food intake rapidly without maintaining fluid and salt intake. Both medications require gradual dose increases (typically every 2–4 weeks) to minimize side effects. PlexusDx patients receive personalized dosing guidance based on their treatment plan, and medications are available in multiple formulations including oral tirzepatide and semaglutide for those who prefer not to inject.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Will I lose more weight on Zepbound than Wegovy?
Clinical trials show tirzepatide users lose approximately 3–5% more body weight than semaglutide users on average, but individual results vary widely based on genetics, lifestyle, and dose adherence. PlexusDx offers compounded tirzepatide injection starting at $249/mo, providing the weight loss advantage of the dual-receptor mechanism at accessible pricing.
Why does tirzepatide cause more weight loss than semaglutide?
Tirzepatide activates both GLP-1 and GIP receptors, triggering stronger appetite suppression and potentially higher metabolic activation than semaglutide's single GLP-1 pathway. The dual mechanism makes tirzepatide more potent for most patients, though genetic variants in your GIPR and GLP1R genes influence how much benefit you personally receive from each pathway.
How much does PlexusDx tirzepatide cost compared to Zepbound?
PlexusDx compounded tirzepatide injection starts at $249/mo with no flat per-compound pricing increases, whereas Zepbound typically costs $900–$1,300 monthly without insurance. PlexusDx serves all 50 states, requires no insurance or membership fee, and accepts HSA/FSA funds for additional savings.
Are compounded tirzepatide and semaglutide as safe as brand-name versions?
PlexusDx medications are compounded by licensed 503A pharmacies meeting rigorous FDA standards for sterility, potency, and purity. Compounded tirzepatide contains identical active ingredients as Zepbound, with safety profiles supported by the same clinical trial data. Always inform your provider of any health conditions or medications before starting.
Can genetic testing predict whether I'll respond better to tirzepatide or semaglutide?
Yes—PlexusDx Precision Peptide Genetic Test identifies variants in GLP1R (rs6923761), GIPR (rs1800437), FTO, and MC4R genes that predict your metabolic response pattern. This genetic insight helps determine whether you're more likely to benefit from tirzepatide's dual-receptor activation or semaglutide's single-pathway approach, available as a $99 add-on after your first treatment month.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How Zepbound is Injected: A Step-by-Step Guide to Your Weight Loss Journey
How Much Weight Loss in the First Month of Wegovy: Insights and Expectations